Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART)
Background Though stereotactic body radiation therapy (SBRT) has been widely used in advanced tumors, ablative doses may not be appropriate in the case of large tumors or those abutting to the gastrointestinal tracts, resulting in unfavorable outcomes. Therefore, partial irradiation with high doses...
Saved in:
| Main Authors: | Lingong Jiang MD, Yangsen Cao MD, Xiaolan Yin MD, Chunshan Yu MD, Yusheng Ye MD, Xiaofei Zhu MD, Huojun Zhang MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Technology in Cancer Research & Treatment |
| Online Access: | https://doi.org/10.1177/15330338251350833 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase 2 Trial of Stereotactic Body Radiation Therapy with Dose Escalation Using Simultaneous Integrated Boost for Spinal Metastases
by: Takamasa Mitsuyoshi, MD, PhD, et al.
Published: (2025-06-01) -
Response to Central Boost Radiation Therapy in Unresectable Retroperitoneal Sarcoma: A Case Series
by: Danielle N. Burner, BS, et al.
Published: (2025-02-01) -
Efficacy and Safety of Simultaneous Integrated Boost Followed by Selective Sequential Boost Radiotherapy for Spinal Metastases: A Single-Arm Retrospective Study
by: Hui Xiao BS, et al.
Published: (2025-08-01) -
A rare tamponade after percutaneous ablation operationCentral Message
by: Yingjie Ke, MD, et al.
Published: (2024-08-01) -
A Phase I/II Study of Ultra-Hypofractionated Carbon-ion Radiation therapy for Low- and Intermediate-Risk Localized Prostate Cancer
by: Noriyuki Okonogi, MD, PhD, et al.
Published: (2025-03-01)